MedTrace Logo

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

NCT01982383 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-03-27

Study results available
· View outcomes & findings →

Summary

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Conditions

  • Central Serous Chorioretinopathy

Interventions

DEVICE

Micropulse Laser Treatment

OTHER

No treatment

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Principal Investigators

  • Jeevan Mathura, MD · George Washington University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982383 on ClinicalTrials.gov